EUVIMEDScopri EUVIMED
Fallbericht

Recurrent gastrointestinal bleeding after Peptide Receptor Radionuclide Therapy for a small intestine neuroendocrine tumor

C Brackenier, H Leupe, J Dekervel, C Verslype, G De Hertogh, H Topal, G Rasschaert, C M Deroose, F Van Herpe

Acta Gastro Enterologica Belgica · 2026-03-30 · 91 (1) · 83

DOI: 10.51821/89.1.14522 ↗

At a glance

Fallbericht in Acta Gastro Enterologica Belgica, published online on 2026-03-02. Written by C Brackenier and 8 co-authors. Institution: Department of Gastro-enterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

We report a case of a patient who received three cycles of Peptide Receptor Radionuclide Therapy (PRRT) with [177Lu] Lu-DOTATATE for a small intestine neuroendocrine tumor (siNET) and developed recurrent GI (gastrointestinal) bleeding. These complications required four admissions on intensive care unit (ICU), transfusion of fourteen units of packed cells and finally surgery. Radiation safety precautions were respected at all hospital wards. Histopathology of the culprit lesion did not reveal tumor, but showed a large-caliber angiodysplastic lesion. The somatostatin receptor (SSTR) positive tumor consisted of a confluent mass of adenopathies invading the mesenteric vein. We hypothesize the amino-acid infusion, which is supportive therapy given prior to PRRT, caused vasodilatation in the pre-existing angiodysplastic lesion. The vasodilatation together with the high venous pressure due to tumoral invasion of the mesenteric vein may have aggravated bleeding symptoms.

Subjects

Author keywords

gastrointestinal bleedingneuroendocrine tumorradiation protectionradionuclide therapy

Authors and institutions

  • Department of Gastro-enterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
  • Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Department of Abdominal Surgery, University Hospitals Leuven, Leuven, Belgium.

Cite

APA

Brackenier, C., Leupe, H., Dekervel, J., Verslype, C., De Hertogh, G., Topal, H., Rasschaert, G., Deroose, C. M., & Van Herpe, F. (2026). Recurrent gastrointestinal bleeding after Peptide Receptor Radionuclide Therapy for a small intestine neuroendocrine tumor. Acta Gastro Enterologica Belgica, 91(1), 83. https://doi.org/10.51821/89.1.14522

Vancouver

Brackenier C, Leupe H, Dekervel J, Verslype C, De Hertogh G, Topal H, et al. Recurrent gastrointestinal bleeding after Peptide Receptor Radionuclide Therapy for a small intestine neuroendocrine tumor. Acta Gastro Enterologica Belgica. 2026;91(1):83. doi:10.51821/89.1.14522

BibTeX
@article{Brackenier2026,
  author = {Brackenier, C and Leupe, H and Dekervel, J and Verslype, C and De Hertogh, G and Topal, H and Rasschaert, G and Deroose, C M and Van Herpe, F},
  title = {Recurrent gastrointestinal bleeding after Peptide Receptor Radionuclide Therapy for a small intestine neuroendocrine tumor},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2026},
  volume = {91},
  number = {1},
  pages = {83},
  doi = {10.51821/89.1.14522}
}
Start for free →